Drugs / verteporphin
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02321267 Background | Dec 2014 → Dec 2024 | macular degeneration | Kagawa University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | verteporphin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02321267 ↗ |
| Route | Intravenous | “verteporphin, iv, 6mg/㎡” NCT02321267 ↗ |